Abstract
The role of clinical pharmacy in the health care system is changing rapidly. This change is almost universal among different countries and is related to developments in medical technology, health economics, informatics, socio‐economic status, and professional relations.Transitions to new systems of clinical pharmacy are difficult to anticipate. Even with well defined targets, it remains uncertain what the future of clinical pharmacy will bring us. The construction of plausible scenarios may help us better in preparing for the 'new world' ahead.
At the annual congresses of ESCP in Prague 1995 (24th) and Lisbon 1996 (25th), a number of scenario analysis workshops with respect to the future of clinical pharmacy were organized. This paper gives a report of the results of these scenario sessions and reflects on the implications for future policy making. After we identified the driving forces behind the future of clinical pharmacy, various sets of assumptions were made and from them scenarios were constructed which are plausible: they 'could' happen. This analysis provided a logical framework in which we ultimately depicted three alternating stories of the future of clinical pharmacy, named 'CLERK', 'CONTROLLER' and 'CARE MANAGER'. These scenarios are intended to help clinical pharmasists to break free of familiar mental maps and to stimulate creative thinking on the future.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
European Society of Clinical Pharmacy. The clinical pharmacist: education document. Barcelona, 1983.
Breimer DD, ed. Roles and responsibilities of the pharmacists in primary health care. Proceedings of the 42nd international congress of FIP, Copenhagen 1982. The Hague, 1983.
Lunde I, Dukes MNG. The role and functions of the community and hospital pharmacist in the health care systems in Europe. WHO Collaborating Centre for Clinical Pharmacology and Drug Policy Science, University of Groningen, 1989.
Pharmacy, a report to the Nuffield Foundation. London: The Nuffield Foundation, 1986.
Bonal J, Burden M, Delporte JP, eds. The future of clinical pharmacy in Europe. Noordwijk: European Society of Clinical Pharmacy, 1993.
Waldo DR, Sonnefeld ST, Lemieux JA, McKusick DR. Health spending through 2030: Three Scenarios. Health Affair 1991; 231–42.
Anonymous. Hard to swallow-the cost of drugs. Economist 1992; April 18th:87.
Dukes MNG. Pharmaceuticals: take another look. Pharm Weekbl 1985; 120: 532–8.
Reinhardt UE, Pinto FJ, eds. New perspectives in health care economics. MEDIQ Ltd, London 1991.
UK Clinical Pharmacy Association Statement on Pharmaceutical Care. Pharmaceutical Journal 1996; 256: 345–6.
Schwartz P. The art of the long view. Planning for the future in an uncertain world. New York: Bantam Books, 1991.
Leufkens H, Haaijer-Ruskamp F, Bakker A, Dukes G. Scenario analysis of the future of medicines. Br Med J 1994; 309: 1136–40.
McAllister JC 3rd. Collaborating with re-engineering consultants: maintaining resources for the future. Am J Health Syst Pharm 1995; 52(23): 2676–80.
Keys PW, Goetz CM, Keys PA, Sterchele JA, Snedden TM, Livengood BH. Computer-guided academic detailing as part of a drug benefit program. Am J Health Syst Pharm 1995; 2199–203.
Talley CR. Outsourcing drug distribution. Am J Health-Syst Pharm 1997; 54:37.
American College of Clinical Pharmacy. Rewards and advancements for clinical pharmacy practitioners. Pharmacotherapy 1995 Jan-Feb;15(1): 99–105.
Birenbaum A. Reprofessionalization in pharmacy. Soc Sci Med 1982; 16: 871–8.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Leufkens, H., Hekster, Y. & Hudson, S. Scenario analysis of the future of clinical pharmacy.. Pharm World Sci 19, 182–185 (1997). https://doi.org/10.1023/A:1008625231054
Issue Date:
DOI: https://doi.org/10.1023/A:1008625231054